Mytrex Health Technologies, Inc. (TPEX:4431)
Taiwan · Delayed Price · Currency is TWD 18.75
0.00 (0.00%)
Aug 21, 2026, 1:31 PM CST
TPEX:4431 Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 2,053 | 1,945 | 1,759 | 1,293 | 1,472 | 291.62 |
Revenue Growth | 5.56% | 10.59% | 36.02% | -12.14% | 404.61% | -71.51% |
Gross Profit Gross Profit Growth | 241.19 | 242.58 | 221.55 | 192.35 | 239.4 | 40.14 |
Operating Income Operating Income Growth | -15.08 | -25.27 | -77.63 | -71.83 | -46.74 | -15.46 |
Net Income Net Income Growth | -5.32 | -16.6 | -82.38 | -56.22 | -91.9 | -14.01 |
Earnings Per Share EPS Growth | -0.14 | -0.45 | -2.25 | -1.54 | -2.52 | -0.38 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Medicine Distribution Division Medicine Distribution Division Growth | 1,765 | 1,593 | 1,113 | - | - |
Technological Material Business Segment Technological Material Business Segment Growth | 129.71 | 109.8 | 134.77 | 192.23 | 260.47 |
Medical Biotechnology Business Sector (Including Medical Sanitation Materials) Medical Biotechnology Business Sector (Including Medical Sanitation Materials) Growth | 49.77 | 53.33 | 41.23 | 42.58 | 40.38 |
Other Department Other Department Growth | 0.01 | 2.98 | 4.33 | - | 0.64 |
Adjustment and Elimination Adjustment and Elimination Growth | -0.02 | -0.03 | - | -1.73 | -9.19 |
Total Total Growth | 1,945 | 1,759 | 1,293 | 1,472 | 292.29 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 419.87 | 421.63 | 277.52 | 240.75 | 486.53 | 471.21 |
Total Debt Total Debt Growth | 181.14 | 163.07 | 224.44 | 250.67 | 208.83 | 54.51 |
Net Cash (Debt) Net Cash Growth | 238.73 | 258.56 | 53.09 | -9.93 | 277.7 | 416.7 |
Net Cash Growth | -7.67% | 387.05% | - | - | -33.36% | -30.00% |
Net Cash Per Share Net Cash Per Share Growth | 6.41 | 7.08 | 1.45 | -0.27 | 7.60 | 11.41 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 222.84 | 200.5 | 31.63 | -4.26 | 72.48 | 13.29 |
Capital Expenditures CapEx Growth | -4.78 | -4.33 | -8.88 | -21.77 | -35.5 | -29.75 |
Free Cash Flow Free Cash Flow Growth | 218.06 | 196.17 | 22.75 | -26.03 | 36.98 | -16.46 |
Free Cash Flow Growth | 11.16% | 762.17% | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 11.75% | 12.47% | 12.60% | 14.88% | 16.27% | 13.76% |
Operating Margin | -0.73% | -1.30% | -4.41% | -5.56% | -3.18% | -5.30% |
Pretax Margin | -0.29% | -1.11% | -4.79% | -4.42% | -4.20% | -4.66% |
Profit Margin | -0.26% | -0.85% | -4.68% | -4.35% | -6.25% | -4.80% |
FCF Margin | 10.62% | 10.09% | 1.29% | -2.01% | 2.51% | -5.64% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 23, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
P/FCF Ratio | 3.13 | 3.22 | 40.30 | - | 25.00 | - |
PS Ratio | 0.33 | 0.33 | 0.52 | 0.88 | 0.63 | 3.44 |